Association between FDG uptake, CSF biomarkers and cognitive performance in patients with probable Alzheimer’s disease

被引：0
|
作者：
Sönke Arlt
Stefanie Brassen
Holger Jahn
Florian Wilke
Martin Eichenlaub
Ivayla Apostolova
Fabian Wenzel
Frank Thiele
Stewart Young
Ralph Buchert
机构：
[1] University Medical Center Hamburg-Eppendorf,Department of Psychiatry and Psychotherapy
[2] University Medical Center Hamburg-Eppendorf,Institute for Systems Neuroscience
[3] University Medical Center Hamburg-Eppendorf,Department of Nuclear Medicine
[4] Philips Research,Digital Imaging Department
[5] Philips Research,Molecular Imaging Department
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 2009年 / 36卷
关键词：
Alzheimer’s disease; Cerebrospinal fluid; Positron emission tomography; F-Fluorodeoxyglucose; Statistical parametric mapping;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1090 / 1100
页数：10
相关论文
共 50 条
  • [31] Age and diagnostic performance of Alzheimer disease CSF biomarkers
    Mattsson, N.
    Rosen, E.
    Hansson, O.
    Andreasen, N.
    Parnetti, L.
    Jonsson, M.
    Herukka, S. -K.
    van der Flier, W. M.
    Blankenstein, M. A.
    Ewers, M.
    Rich, K.
    Kaiser, E.
    Verbeek, M. M.
    Rikkert, M. Olde
    Tsolaki, M.
    Mulugeta, E.
    Aarsland, D.
    Visser, P. J.
    Schroeder, J.
    Marcusson, J.
    de Leon, M.
    Hampel, H.
    Scheltens, P.
    Wallin, A.
    Eriksdotter-Jonhagen, M.
    Minthon, L.
    Winblad, B.
    Blennow, K.
    Zetterberg, H.
    NEUROLOGY, 2012, 78 (07) : 468 - 476
  • [32] Chemokines in CSF of Alzheimer's disease patients
    Correa, Joice Dias
    Starling, Daniela
    Teixeira, Antonio Lucio
    Caramelli, Paulo
    Silva, Tarcilia Aparecida
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2011, 69 (03) : 455 - 459
  • [33] Cognitive reserve and Alzheimer's disease biomarkers are independent determinants of cognition
    Vemuri, Prashanthi
    Weigand, Stephen D.
    Przybelski, Scott A.
    Knopman, David S.
    Smith, Glenn E.
    Trojanowski, John Q.
    Shaw, Leslie M.
    Decarli, Charlie S.
    Carmichael, Owen
    Bernstein, Matt A.
    Aisen, Paul S.
    Weiner, Michael
    Petersen, Ronald C.
    Jack, Clifford R., Jr.
    BRAIN, 2011, 134 : 1479 - 1492
  • [34] White matter hyperintensity volume modifies the association between CSF vascular inflammatory biomarkers and regional FDG-PET along the Alzheimer's disease continuum
    Tubi, Meral A.
    Wheeler, Koral
    Matsiyevskiy, Elizabeth
    Hapenney, Matthew
    Mack, Wendy J.
    Chui, Helena C.
    King, Kevin
    Thompson, Paul M.
    Braskie, Meredith N.
    NEUROBIOLOGY OF AGING, 2023, 132 : 1 - 12
  • [35] CSF cortisol in Alzheimer's disease and mild cognitive impairment
    Popp, Julius
    Schaper, Karsten
    Koelsch, Heike
    Cvetanovska, Gabriela
    Rommel, Fatima
    Klingmueller, Dietrich
    Dodel, Richard
    Wuellner, Ullrich
    Jessen, Frank
    NEUROBIOLOGY OF AGING, 2009, 30 (03) : 498 - 500
  • [36] Study on the association between SOAT1 polymorphisms, Alzheimer's disease risk and the level of CSF biomarkers
    Laemsae, R.
    Helisalmi, S.
    Herukka, S.-K.
    Tapiola, T.
    Pirttilae, T.
    Vepsaelaeinen, S.
    Hiltunen, M.
    Soininen, H.
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2007, 24 (02) : 146 - 150
  • [37] Heterogeneity of Effects of Cognitive Reserve on Performance in Probable Alzheimer's Disease and in Subjective Cognitive Decline
    Montemurro, Sonia
    Mondini, Sara
    Arcara, Giorgio
    NEUROPSYCHOLOGY, 2021, 35 (08) : 876 - 888
  • [38] Alzheimer’s disease CSF biomarkers: clinical indications and rational use
    Ellis Niemantsverdriet
    Sara Valckx
    Maria Bjerke
    Sebastiaan Engelborghs
    Acta Neurologica Belgica, 2017, 117 : 591 - 602
  • [39] Decision tree supports the interpretation of CSF biomarkers in Alzheimer's disease
    Mofrad, Rosha Babapour
    Schoonenboom, Niki S. M.
    Tijms, Betty M.
    Scheltens, Philip
    Visser, Pieter Jelle
    van der Flier, Wiesje M.
    Teunissen, Charlotte E.
    ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING, 2019, 11 (01) : 1 - 9
  • [40] Use of CSF biomarkers in the diagnosis of Alzheimer's disease in clinical practice
    Koric, L.
    Felician, O.
    Ceccaldi, M.
    REVUE NEUROLOGIQUE, 2011, 167 (6-7) : 474 - 484
12345